Garenc Christophe, Aubert Samuel, Laroche Jerôme, Bergeron Jean, Gagné Claude, Rousseau François, Julien Pierre
Department of Medicine, Lipid Research Center (CRML), Centre de Recherche du Centre Hospitalier de l'Université Laval du CHUQ, TR-93, Laval University, Sainte-Foy, Que., Canada G1V 4G2.
Biochem Biophys Res Commun. 2006 Jun 2;344(2):588-96. doi: 10.1016/j.bbrc.2006.03.187. Epub 2006 Apr 6.
In Eastern Québec, two major lipoprotein lipase (LPL) gene mutations, P207L and G188E, lead to complete LPL deficiency in homozygote subjects and contribute to elevated predisposition to hypertriglyceridemia in heterozygotes. First, we determined the allele frequencies of LPL (D9N, G188E, P207L, D250N, N291S, and S447X), APOE (C112R and C158R), PPARalpha (L162V), and PPARgamma2 (P12A) single nucleotide polymorphisms (SNPs) in a random-based cohort of the metropolitan Québec city area. Second, we compared the LPL X447 allele frequencies observed in the random cohort and in a cohort of LPL P207L deficient patients. In the random cohort, the LPL N9 rare allele exhibited a higher prevalence than previously expected (p=0.0001). The LPL X447 allele frequency was lower in the patient cohort (Freq: 4.4%) than in the random cohort (Freq: 11.2%) (p=0.0001). These results reveal the importance of genetic screening for LPL gene mutations D9N and S447X in a population at risk to develop hypertriglyceridemia.
在魁北克东部,两种主要的脂蛋白脂肪酶(LPL)基因突变,即P207L和G188E,会导致纯合子个体出现完全性LPL缺乏,并使杂合子个体患高甘油三酯血症的易感性增加。首先,我们在魁北克市大都市区一个基于随机抽样的队列中,确定了LPL(D9N、G188E、P207L、D250N、N291S和S447X)、载脂蛋白E(APOE,C112R和C158R)、过氧化物酶体增殖物激活受体α(PPARalpha,L162V)和过氧化物酶体增殖物激活受体γ2(PPARgamma2,P12A)单核苷酸多态性(SNP)的等位基因频率。其次,我们比较了在随机队列和LPL P207L缺乏患者队列中观察到的LPL X447等位基因频率。在随机队列中,LPL N9罕见等位基因的患病率高于先前预期(p = 0.0001)。患者队列中的LPL X447等位基因频率(频率:4.4%)低于随机队列(频率:11.2%)(p = 0.0001)。这些结果揭示了对有患高甘油三酯血症风险人群进行LPL基因突变D9N和S447X基因筛查的重要性。